Virtus ETF Advisers’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Virtus ETF Advisers's TNDM Position: Q2 2026 in Review
Virtus ETF Advisers increased its Tandem Diabetes Care (TNDM) stake by 2.5% in Q2 2026, buying an estimated $1.94K and bringing the position to 4,511 shares worth $68.1K. The position accounts for 0.03% of the portfolio, ranked #390.
Virtus ETF Advisers first reported a position in TNDM in Q1 2026 and has held it in 2 quarters since. The position peaked at $84.3K in Q1 2026. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Virtus ETF Advisers held 4,511 shares of Tandem Diabetes Care worth $68.1K as of Q2 2026.
- Virtus ETF Advisers bought 111 Tandem Diabetes Care shares in Q2 2026, an estimated $1.94K.
- Tandem Diabetes Care made up 0.03% of Virtus ETF Advisers's portfolio in Q2 2026, its #390 holding.
- Virtus ETF Advisers first reported a position in Tandem Diabetes Care in Q1 2026 and has held it in 2 quarters since.
- Virtus ETF Advisers's Tandem Diabetes Care position peaked at $84.3K in Q1 2026.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Virtus ETF Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.